UBS Group Initiates Coverage on Docusign (NASDAQ:DOCU)

Research analysts at UBS Group started coverage on shares of Docusign (NASDAQ:DOCU – Get Free Report) in a research report issued to clients and investors on Thursday, Benzinga reports. The firm set a “neutral” rating and a $85.00 price target on the stock. UBS Group‘s price objective would suggest a potential upside of 14.00% from the stock’s current price.

DOCU has been the topic of several other reports. Robert W. Baird lifted their target price on shares of Docusign from $55.00 to $72.00 and gave the stock a “neutral” rating in a research report on Friday, September 4th. Wall Street Zen cut shares of Docusign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 2nd. Weiss Ratings upgraded shares of Docusign from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Wells Fargo & Company raised their price target on shares of Docusign from $55.00 to $60.00 and gave the company an “equal weight” rating in a research note on Friday, September 4th. Finally, Piper Sandler raised their price target on shares of Docusign from $52.00 to $75.00 and gave the company a “neutral” rating in a research note on Friday, September 4th. Three research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Docusign currently has an average rating of “Hold” and an average price target of $69.50.

Read Our Latest Stock Report on Docusign

Docusign Trading Down 0.7%

NASDAQ:DOCU opened at $74.56 on Thursday. The stock has a market cap of $13.94 billion, a P/E ratio of 47.51, a price-to-earnings-growth ratio of 2.94 and a beta of 0.80. The stock’s 50-day moving average is $75.06 and its 200-day moving average is $56.40. Docusign has a 1-year low of $40.16 and a 1-year high of $85.90.

Docusign (NASDAQ:DOCU – Get Free Report) last released its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.09 by $0.07. Docusign had a return on equity of 18.29% and a net margin of 9.82%. The company had revenue of $875.75 million during the quarter, compared to the consensus estimate of $867.22 million. During the same quarter in the prior year, the firm posted $0.30 earnings per share. The firm’s revenue was up 9.4% compared to the same quarter last year. As a group, equities analysts forecast that Docusign will post 2.15 EPS for the current year.

Insider Buying and Selling

In other news, CFO Blake Grayson sold 30,000 shares of the business’s stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $70.00, for a total value of $2,100,000.00. Following the transaction, the chief financial officer directly owned 96,429 shares of the company’s stock, valued at $6,750,030. The trade was a 23.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Allan Thygesen sold 26,250 shares of the company’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $69.29, for a total value of $1,818,862.50. Following the sale, the chief executive officer owned 166,801 shares in the company, valued at approximately $11,557,641.29. The trade was a 13.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 154,168 shares of company stock worth $10,491,896 over the last three months. Insiders own 0.59% of the company’s stock.

Hedge Funds Weigh In On Docusign

A number of institutional investors and hedge funds have recently modified their holdings of the business. American Century Companies Inc. increased its stake in shares of Docusign by 27.6% in the 3rd quarter. American Century Companies Inc. now owns 2,336,715 shares of the company’s stock valued at $156,911,000 after acquiring an additional 505,783 shares in the last quarter. Kestra Advisory Services LLC lifted its position in shares of Docusign by 67.8% during the 3rd quarter. Kestra Advisory Services LLC now owns 13,962 shares of the company’s stock valued at $938,000 after acquiring an additional 5,640 shares during the period. Fi3 FINANCIAL ADVISORS LLC acquired a new position in shares of Docusign during the 3rd quarter valued at $299,000. Coastal Bridge Advisors LLC bought a new position in Docusign during the third quarter worth $689,000. Finally, Liontrust Investment Partners LLP bought a new position in Docusign during the third quarter worth $536,000. 77.64% of the stock is currently owned by institutional investors.

About Docusign

(Get Free Report)

DocuSign, Inc. provides software for preparing, signing, managing and automating agreements. Its platform helps businesses and individuals complete agreements digitally, reducing reliance on paper-based processes. The company’s offerings include DocuSign eSignature, which enables users to sign and request signatures electronically, as well as tools for contract lifecycle management and agreement workflows. Its Intelligent Agreement Management products use artificial intelligence to help organizations analyze and manage agreement-related information and processes.

Further Reading

Analyst Recommendations for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.